Vedida

Medicinal product

(Invented) name

Vedida

Active substance (s)

Vorikonazolas

Strength

200 mg

Pharmaceutical form

milteliai infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J02AC03, Voriconazole

Marketing authorisation holder

Medochemie Ltd., Kipras

Date of authorisation

2021-05-17

Date of renewal

Documents

4745 Pakuotės lapelis 2024 12 05.docx

VEDIDA sveikatos prieziuros specialisto klausimu ir atsakymu brosiura.pdf

VEDIDA paciento kortele.pdf

4745 Vedida PCS PL 2024 12 05.docx

VEDIDA mokomoji medziaga sveikatos prieziuros specialistams.pdf

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/5075/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra:	1 vnt.
Vorikonazolas	200 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106537	92638	1092638	flakonas	N1		Receptinis	LT/1/21/4745/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-12-31	Išregistruotas
2021-05-17	Registruotas